Clinical Results - Lumenis Aesthetic
Clinical Results - Lumenis Aesthetic
Clinical Results - Lumenis Aesthetic
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ActiveFX to MaxFX<br />
<strong>Clinical</strong> <strong>Results</strong><br />
BEFORE<br />
ActiveFX<br />
AFTER<br />
MaxFX<br />
Fractional to Total CO 2 Laser Skin Resurfacing<br />
Tone, Texture and Tightening * with UltraPulse ® Encore <br />
www.lumenis.com • www.aesthetic.lumenis.com
ActiveFX<br />
to MaxFX<br />
The Gold-Standard for Tone, Texture and Tightening*<br />
BEFORE<br />
AFTER<br />
BEFORE<br />
Pigment Dyschromia<br />
Courtesy of Joseph Niamtu III, DMD<br />
Eyelid Laxity<br />
Courtesy of Glenn A. DeBias, DO<br />
Pigment Dyschromia and Rhytids<br />
Courtesy of Barry E. DiBernardo, MD<br />
Dyschromia and Sun Damage<br />
Courtesy of Joseph Niamtu III, DMD<br />
Pigment Dyschromia<br />
Courtesy of Jeffery M. Kenkel, MD<br />
Periorbital Wrinkles<br />
Courtesy of Glenn A. DeBias, DO
Single<br />
Treatment<br />
Achieve profound results in a SINGLE treatment. The UltraPulse ® Encore system is flexible,<br />
allowing physicians to tailor treatments to suit each patient’s needs.<br />
ActiveFX is a fractional laser treatment that yields remarkable results with minimal<br />
downtime – most patients resume normal activity in 3–5 days.<br />
MaxFX is a deeper treatment that provides truly dramatic results for more severe<br />
enviromental damage and deep lines.<br />
AFTER<br />
BEFORE<br />
AFTER<br />
Upper Eyelid Blepharoplasty<br />
Courtesy of Kent B. Remington, MD<br />
Solar Elastosis<br />
Courtesy of Suzanne L. Kilmer, MD<br />
Keloid Scars<br />
Courtesy of Kent B. Remington, MD
AESTHETIC<br />
LUMENIS. ENHANCING LIFE. ADVANCING TECHNOLOGY.<br />
UltraPulse® Encore<br />
BEFORE<br />
AFTER<br />
Keratosis<br />
Courtesy of Joseph Niamtu III, DMD<br />
Rhynophyma<br />
Courtesy of Joseph Niamtu III, DMD<br />
Railan D, Kilmer S. Ablative Treatment of Photoaging. Dermatology Therapy 18:227-241, 2005.<br />
*<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<strong>Lumenis</strong> Corporate Office<br />
<strong>Lumenis</strong> Inc.<br />
<strong>Lumenis</strong> (GERMANY) GmbH<br />
<br />
<strong>Lumenis</strong> (JAPAN) Co. Ltd.<br />
<strong>Lumenis</strong> Ltd.<br />
Santa Clara, CA, USA Dreieich-Dreieichenhain,<br />
Tokyo, Japan<br />
<br />
Yokneam, Israel<br />
Tel +1 408 764 3000 Germany<br />
Tel + 81 3 5789 8300<br />
Tel + 972 4 959 9000<br />
1 877 586 3647 Tel + 49 6103 8335 0 <br />
Fax + 81 3 5789 8310<br />
Fax + 972 4 959 9050<br />
<br />
Fax +1 408 764 3999 Fax + 49 6103 8335 300 <br />
1 800 505 1133<br />
<br />
<strong>Lumenis</strong> (CHINA) Ltd.<br />
Beijing, China<br />
Tel + 86 10 6510 2620<br />
Fax + 86 10 6510 2621<br />
<br />
<br />
©2007, the <strong>Lumenis</strong> Group of Companies. All rights reserved. <strong>Lumenis</strong>, its logo, ActiveFX, MaxFX and UltraPulse Encore are trademarks or registered trademarks of the <strong>Lumenis</strong><br />
Group of Companies. Specifications are subject to change without notice.<br />
ev.A<br />
PB-000081 rev.A
Change language